Premium
Fate Therapeutics Inc (FATE)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, includ... Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.28 | -18.5430463576 | 1.51 | 1.81 | 1.18 | 3029859 | 1.51159854 | CS |
| 4 | -0.07 | -5.38461538462 | 1.3 | 1.81 | 1.165 | 2204105 | 1.43237004 | CS |
| 12 | -1.43 | -53.7593984962 | 2.66 | 2.93 | 1.04 | 2703700 | 1.66382214 | CS |
| 26 | -2.69 | -68.6224489796 | 3.92 | 4.2 | 1.04 | 2337887 | 2.22700546 | CS |
| 52 | -5.73 | -82.3275862069 | 6.96 | 8.83 | 1.04 | 2341662 | 3.61065132 | CS |
| 156 | -33.77 | -96.4857142857 | 35 | 43.12 | 1.04 | 2233941 | 8.27742338 | CS |
| 260 | -29.48 | -95.9947899707 | 30.71 | 121.16 | 1.04 | 1759385 | 20.5828624 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
